Africa News Ledger
SEE OTHER BRANDS

The most trusted news from Africa

Africa News Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.

Press releases published on May 7, 2025

MMEC 2025 Kicks Off with Strategic Partnerships, Presidential Vision, and Bold Energy Commitments

MMEC 2025 Kicks Off with Strategic Partnerships, Presidential Vision, and Bold Energy Commitments

MAPUTO, MOZAMBIQUE, May 7, 2025 /⁨EINPresswire.com⁩/ -- The 11th edition of the Mozambique Mining and Energy Conference (MMEC 2025) officially began today in Maputo, setting the stage for transformative dialogue, cross-sector partnerships, and a renewed …

Weber Legal Nurse Consulting Observes National Women’s Health Month; Urges Women to Prioritize Their Health

Weber Legal Nurse Consulting Observes National Women’s Health Month; Urges Women to Prioritize Their Health

Weber Legal Nurse Consulting CEO observes women’s health month by sharing preventive measures for women with a genetic link to ovarian cancer, a link she has. PALMDALE, CA, CA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Weber Legal Nurse …

Alliance American University Expands Global Reach with Accredited Programs and Inclusive Online Learning

Alliance American University Expands Global Reach with Accredited Programs and Inclusive Online Learning

Empowering Future Leaders Through Flexible, Accredited, and Inclusive Higher Education DE, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Alliance American University (AAU), a leading institution in global distance learning, continues to set new …

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

MELBOURNE, Australia and INDIANAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been …

Arcadia Finance is Changing the Way South Africans Borrow Money—For the Better

Arcadia Finance is Changing the Way South Africans Borrow Money—For the Better

Arcadia Finance helps South Africans compare loan offers easily, with no fees or bias—empowering smarter, clearer, and more confident borrowing decisions. JOHANNESBURG, GAUTENG, SOUTH AFRICA, May 7, 2025 /⁨EINPresswire.com⁩/ -- Arcadia Finance is Changing …

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte …

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

CTIM-76 and CT-95 in Phase 1 Clinical Trials Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Context …

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

ROCKVILLE, MD, May 7, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

-  Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA -  Lead target and portfolio strategy to be announced mid …

Aardvark Therapeutics to Present at Upcoming Investor Conferences in May

Aardvark Therapeutics to Present at Upcoming Investor Conferences in May

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment …

Century Aluminum Company Reports First Quarter 2025 Results

Century Aluminum Company Reports First Quarter 2025 Results

CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its first quarter 2025 results. First Quarter 2025 Financial Results $MM (except shipments and per share data)   Q1 2025   Q4 2024   Aluminum shipments ( …

Q3 2025 Results: Lesaka delivers on guidance, reaffirms FY2025 outlook and projects positive net income in FY2026

Q3 2025 Results: Lesaka delivers on guidance, reaffirms FY2025 outlook and projects positive net income in FY2026

JOHANNESBURG, May 07, 2025 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the third quarter of fiscal 2025 (“Q3 2025”). Q3 2025 performance: Revenue of $135.7 million (ZAR 2.5 billion) was at the midpoint …

Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Interim Data from Low Dose Cohort in MyPEAKTM-1 Clinical Trial of TN-201 Showed Encouraging Safety Profile, Transduction and Expression, Plus Improvements in Hypertrophy and NYHA Classification RIDGE Natural History and Seroprevalence Study Highlights …

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress

Strong execution of two ongoing Phase 3 trials of daraxonrasib; company expects to substantially complete enrollment of RASolute 302 in patients with pancreatic cancer this year New non-small cell lung cancer clinical data from RAS(ON) inhibitor portfolio …

Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference

Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference

NEWTON, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s …

Intellect Appoints Eshmael Mpabanga as Country Head for South Africa

Intellect Appoints Eshmael Mpabanga as Country Head for South Africa

CHENNAI, INDIA, May 7, 2025 /⁨EINPresswire.com⁩/ -- As South Africa accelerates efforts to realise the goals of its National Development Plan (NDP 2030) focused on inclusive economic growth and digital transformation, global technology firms have a unique …

Bessor Announces Changes to the Board

Bessor Announces Changes to the Board

Vancouver, BC, May 07, 2025 (GLOBE NEWSWIRE) -- Bessor Minerals Inc. (TSXV:BST) ("Bessor" or the “Corporation”) announces Mr. Kieran Downes has resigned as a director of the Corporation. Mr. Downes resigned in order to pursue personal interests unrelated …

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…

Scenic Biotech Announces Nature Publication on the Discovery of Drug Target PLA2G15, a Modifier in Lysosomal Disease

Scenic Biotech Announces Nature Publication on the Discovery of Drug Target PLA2G15, a Modifier in Lysosomal Disease

In collaboration with a Stanford University research team, Scenic Biotech identified and characterized PLA2G15 as a novel target in lysosomal storage diseases Amsterdam, the Netherlands, May 07, 2025 – Scenic Biotech, a pioneer in the field of modifier …

Lithium Argentina Publishes 2024 Sustainability Report

Lithium Argentina Publishes 2024 Sustainability Report

ZUG, Switzerland, May 07, 2025 (GLOBE NEWSWIRE) -- Lithium Argentina AG. (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) announces the release of its 2024 Sustainability Report, “Lithium With Purpose” (the “Report”). The Report highlights the …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service